Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and Disease    2017, Vol. 8 Issue (5) : 685-687     DOI: 10.14336/AD.2017.0822
Editorial |
Molecular Connections of Aging and Cancer
William C. Cho
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong
Download: PDF(475 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Corresponding Authors: William C. Cho   
Issue Date: 27 September 2017
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
William C. Cho
Cite this article:   
William C. Cho. Molecular Connections of Aging and Cancer[J]. A&D, 2017, 8(5): 685-687.
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2017.0822     OR     http://www.aginganddisease.org/EN/Y2017/V8/I5/685
[1] Siegel RL, Miller KD, Jemal A (2016). Cancer statistics, 2016. CA Cancer J Clin, 66:7-30.
http://dx.doi.org/10.3322/caac.21332
[2] Hsu T (2016). Educational initiatives in geriatric oncology - who, why, and how?. J Geriatr Oncol, 7:390-396.
http://dx.doi.org/10.1016/j.jgo.2016.07.013
[3] Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013). The hallmarks of aging. Cell, 153:1194-1217.
http://118.145.16.217/magsci/article/article?id=19655884
[4] Stegeman R, Weake VM (2017). Transcriptional signatures of aging. J Mol Biol, 429(16):2427-2437.
http://dx.doi.org/10.1016/j.jmb.2017.06.019
[5] Aunan JR, Cho WC, Søreide K (2017). The biology of aging and cancer: a brief overview of shared and divergent molecular hallmarks. Aging Dis, 8: 616-630.
[6] Saraswat K, Rizvi SI (2017). Novel strategies for anti-aging drug discovery. Expert Opin Drug Discov, 11:1-12.
[7] McCubrey JA, Lertpiriyapong K, Steelman LS, Abrams SL, Yang LV, Murata RM, et al. (2017). Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. Aging (Albany NY), 9(6):1477-1536.
[8] Babashah S, Bakhshinejad B, Birgani MT, Pakravan K, Cho WC (2017). Regulation of microRNAs by phytochemicals: a promising strategy for cancer chemoprevention. Curr Cancer Drug Targets. 2017 Jun 23. doi: .[Epub ahead of print]
doi: 10.2174/1568009617666170623124710
[9] Menendez JA, Alarcón T (2017). Senescence-inflammatory regulation of reparative cellular reprogramming in aging and cancer. Front Cell Dev Biol, 5:49.
http://dx.doi.org/10.3389/fcell.2017.00049
[10] Cho WC, Kwan CK, Yau S, So PP, Poon PC, Au JS (2011). The role of inflammation in the pathogenesis of lung cancer. Expert Opin Ther Targets, 15(9):1127-1137.
http://dx.doi.org/10.1517/14728222.2011.599801
[11] Zinger A, Cho WC, Ben-Yehuda A (2017). Cancer and aging - the inflammatory connection. Aging Dis, 8: 599-615.
[12] Raffaghello L, Longo V (2017). Metabolic alterations at the crossroad of aging and oncogenesis. Int Rev Cell Mol Biol, 332:1-42.
http://dx.doi.org/10.1016/bs.ircmb.2017.01.003
[13] Tomasetti C, Li L, Vogelstein B (2017). Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science, 355(6331):1330-1334.
http://dx.doi.org/10.1126/science.aaf9011
[14] Tidwell TR, Søreide K, Hagland HR (2017). Aging, metabolism, and cancer development: from Peto’s paradox to the Warburg effect. Aging Dis, 8: 662-676.
[15] Urzua U, Chacon C, Lizama L, Sarmiento S, Villalobos P, Kroxato B, et al. (2017). Parity history determines a systemic inflammatory response to spread of ovarian cancer in naturally aged mice. Aging Dis, 8: 631-642.
[16] Wright JD, Chen L, Tergas AI, Patankar S, Burke WM, Hou JY, et al. (2015). Trends in relative survival for ovarian cancer from 1975 to 2011. Obstet Gynecol, 125:1345-1352.
http://dx.doi.org/10.1097/AOG.0000000000000854
[17] Janda M, Youlden DR, Baade PD, Jackson D, Obermair A (2008). Elderly patients with stage III or IV ovarian cancer: should they receive standard care?. Int J Gynecol Cancer, 18:896-907.
http://dx.doi.org/10.1111/j.1525-1438.2007.01122.x
[18] Tortorella L, Vizzielli G, Fusco D, Cho WC, Bernabei R, Scambia G, et al. (2017). Ovarian cancer management in the oldest old: improving outcomes and tailoring treatments. Aging Dis, 8: 677-684.
[19] Donaldson MR, Coldiron BM (2011). No end in sight: the skin cancer epidemic continues. Semin Cutan Med Surg, 30(1):3-5.
http://118.145.16.217/magsci/article/article?id=15332970
[20] Garcovich S, Colloca G, Sollena P, Bellieni A, Balducci L, Cho WC, et al. (2017). Skin cancer epidemics in the elderly as an emerging issue in geriatric oncology. Aging Dis, 8: 643-616.
[21] Nolen SC, Evans MA, Fischer A, Corrada MM, Kawas CH, Bota DA (2017). Cancer-Incidence, prevalence and mortality in the oldest-old. A comprehensive review. Mech Ageing Dev, 164:113-126.
http://dx.doi.org/10.1016/j.mad.2017.05.002
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd